After a flurry of positive results from clinical trials of COVID-19 vaccines, developers are now seeking ‘emergency use’ approvals, which could see these immunizations deployed in potentially tens of millions of people. But scientists are concerned that this kind of early deployment could compromise the ongoing clinical trials that seek to show conclusively how well the vaccines work.
You are here
Thu, 2012-11-15 22:48 — mdmcdonald
This working group is focused on discussions about health issues.
The mission of this working group is to focus on discussions about health issues.
Add Content to this group
Members
Albert Gomez | Kathy Gilbeaux | mdmcdonald | mike kraft |
Email address for group
health-ny@m.resiliencesystem.org
Recent Comments